Related Experiment Video
Updated: Dec 3, 2025
08:53
Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness
Published on: August 31, 2016
15.7K
Family caregivers' support needs during allo-HSCT-a longitudinal study
Annika M Kisch1,2, Karin Bergkvist3,4, Anette Alvariza5
1Haematology Department, Lund University Hospital, Lund, Sweden. annika.kisch@med.lu.se.
Summary
Family caregivers of allogeneic hematopoietic stem cell transplant (allo-HSCT) recipients need ongoing support, as most needs persist post-transplant and are linked to poorer outcomes.
Area of Science:
- Hematology
- Oncology
- Psychology
Background:
- Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a complex procedure.
- Family caregivers play a crucial role in patient recovery and well-being.
- Understanding caregiver support needs is vital for optimizing care.
Purpose of the Study:
- To investigate the support needs of family caregivers before and after allo-HSCT.
- To examine how these needs evolve over time.
- To identify associations between needs, caregiver demographics, and outcomes.
Main Methods:
- Longitudinal study of 87 family caregivers of allo-HSCT recipients.
- Utilized the Carer Support Needs Assessment Tool (CSNAT) and caregiver outcome measures.
- Data collected pre-transplant and at 3, 6, and 16 weeks post-transplant.
Main Results:
- Top pre-transplant needs: 'knowing what to expect' (79%) and 'dealing with own feelings' (70%).
- Higher support needs correlated with younger age, non-partner status, and worse caregiver outcomes.
- Most support needs remained consistent throughout the follow-up period.
Conclusions:
- Significant caregiver support needs persist post-allo-HSCT.
- High support needs are linked to adverse caregiver outcomes.
- Increased attention and resources are necessary for family caregivers in allo-HSCT settings.
Related Concept Videos
01:22Bone Marrow Sampling and Transplants
669
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
669
01:16Kidney Transplant III: Nursing Management
207
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
207
01:21Stem Cell Therapy for Tissue Regeneration
4.4K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.4K
01:29Documentation in Long-Term and Home Healthcare Setting
1.3K
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
1.3K
01:01Regulation of Hematopoietic Stem Cells
3.7K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.7K
01:19Multipotency of Hematopoietic Stem Cells
3.6K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.6K